The disaster I never imagined having to worry about

Overview

This episode explores the fascinating and alarming phenomenon of disappearing polymorphs, focusing on the case of ritonavir, an HIV medication that was rendered ineffective almost overnight due to a mysterious crystalline transformation. The discussion spans the science of polymorphism, historical scientific debates, and the broader implications for pharmaceuticals and materials science.

Notable Quotes

- It is frightening that this could happen to any drug that we've taken and on which we're dependent. – Abbott Scientist, on the unpredictability of polymorphic transformations.

- Once a more stable form has appeared, it can spread and quickly seed the entire planet. It might be that you will never, ever get the initial polymorph again. – Professor Katharina Fromm, on the irreversible nature of polymorphic shifts.

- The number of polymorphs is proportional to the amount of time and money you spend researching that compound. – Professor Adam Matzger, highlighting the hidden complexities of chemical compounds.

🧪 The Crisis of Ritonavir

- Ritonavir, a life-saving HIV drug, suddenly became ineffective in 1998 due to the emergence of a new, more stable crystalline form (Form II) that did not dissolve properly in the body.

- Despite rigorous quality control and unchanged production processes, the new polymorph spread across manufacturing sites globally, rendering the original Form I impossible to produce.

- Abbott Laboratories ultimately abandoned Form I and reverted to a less effective liquid formulation, underscoring the vulnerability of pharmaceuticals to polymorphic transformations.

💥 Historical Parallels: The Explosive Feud of Liebig and Wöhler

- The episode recounts a 19th-century scientific dispute between chemists Justus von Liebig and Friedrich Wöhler over compounds with identical chemical compositions but vastly different properties.

- Their discovery of isomers—molecules with the same atoms but different arrangements—revolutionized chemistry and laid the groundwork for understanding phenomena like polymorphism.

- Demonstrations of silver cyanate and silver fulminate highlighted how molecular structure dictates behavior, with one compound being stable and the other explosively reactive.

🍫 Polymorphism in Everyday Life: Chocolate as a Case Study

- Chocolate's texture and appearance depend on its crystalline structure, with six possible polymorphs. The desirable Form V is shiny and snappy, while Form IV is dull and soft.

- The process of tempering chocolate involves carefully controlling temperature to encourage the formation of Form V crystals while eliminating less stable forms.

- This analogy helps explain how subtle changes in molecular arrangement can drastically alter material properties, as seen in ritonavir.

❄️ The Tin Pest and Nucleation Phenomena

- The tin pest, a historical phenomenon where tin organ pipes crumbled in cold weather, serves as a metaphor for ritonavir's transformation.

- Once a small amount of gray tin (a different polymorph) formed, it acted as a nucleation site, spreading the transformation to surrounding material.

- Similarly, seed crystals of ritonavir Form II lowered the energy barrier for transformation, causing a cascade that contaminated global production.

🌍 Implications for Pharmaceuticals and Beyond

- Over half of all compounds are polymorphic, and new forms can emerge unpredictably, posing risks to drug efficacy and safety.

- Pharmaceutical companies now invest heavily in polymorph screening to mitigate these risks, but the ritonavir case remains a cautionary tale.

- The episode underscores the need for ongoing research into polymorphism, as even well-studied compounds like aspirin have revealed new forms after decades of use.